Endothelial protection in lung grafts through heparanase inhibition during ex vivo lung perfusion in rats

被引:1
|
作者
Noda, Kentaro [1 ]
Philips, Brian J. [1 ]
Atale, Neha [1 ]
Sanchez, Pablo G. [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Cardiothorac Surg, Div Lung Transplant & Lung Failure, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Cardiothorac Surg, Div Lung Transplant & Lung Failure, UPMC Presbyterian C 900 200 Lothrop St, Pittsburgh, PA 15213 USA
来源
关键词
Lung transplantation; Ex vivo lung perfusion; endothelial glycocalyx; endothelial protection; heparanase; INFLAMMATION; DYSFUNCTION; PATHWAY; ACID;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: We hypothesized that enhancing glycocalyx preservation would reduce endothelial damage in lung grafts during ex-vivo lung perfusion (EVLP) leading to better transplant outcomes. In this study, we characterized the effects of inhibiting heparanase (HPSE), an enzyme responsible for glycocalyx shedding, on lung quality during EVLP. METHODS: Human clinical EVLP perfusate from lung graft patients was utilized to identify a potential association between glycocalyx integrity in grafted lung tissue and clinical data. In addition, we performed pre-clinical studies in which rat lungs underwent normothermic EVLP for 4 hours with/without HPSE inhibitors, heparin (1,000-U/h) or heparastatin (SF4; 1-mM), added to the perfusate. After 4hours EVLP, left lungs were transplanted into syngeneic rats then evaluated for graft quality 2-hours after reperfusion. RESULTS: Clinically, increased degradation of syndecan-1 was identified in dysfunctional grafts during EVLP. Levels of heparan sulfate in perfusate after EVLP were associated with incidence of graft dysfunction after transplantation. In the pre-clinical rat study, SF4 effectively inhibited HPSE activity, and significantly attenuated dissociated glycocalyx levels, endothelial dysfunction, edema, and inflammation in lungs during EVLP compared to both controls and heparin groups. High-doses of heparin demonstrated markedly increased perfusate syndecan-1 concentrations and deteriorated lung quality during EVLP compared with controls. Post-transplant graft function and inflammation were significantly improved in SF4-treated group compared to those in both control and heparin-treated groups. CONCLUSIONS: This study demonstrated that HPSE activity inhibition by SF4 can improve graft preservation during EVLP by protecting the glycocalyx and endothelial function, leading to better lung function following transplantation. (c) 2023 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Ex Vivo Lung Perfusion
    Mariscal A.
    Cypel M.
    Keshavjee S.
    Current Transplantation Reports, 2017, 4 (2) : 149 - 158
  • [22] Ex vivo lung perfusion
    Machuca, Tiago N.
    Cypel, Marcelo
    JOURNAL OF THORACIC DISEASE, 2014, 6 (08) : 1054 - 1062
  • [23] Ex vivo lung perfusion in lung transplantation
    Daisuke Nakajima
    Hiroshi Date
    General Thoracic and Cardiovascular Surgery, 2021, 69 : 625 - 630
  • [24] Ex Vivo Lung Perfusion in Lung Transplantation
    Iyer, Vivek N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (01): : 91 - 92
  • [25] Ex vivo lung perfusion in lung transplantation
    Nakajima, Daisuke
    Date, Hiroshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2021, 69 (04) : 625 - 630
  • [26] Impact of triptolide during ex vivo lung perfusion on grafts after transplantation in a rat model
    Burki, Sarah
    Noda, Kentaro
    Philips, Brian J.
    Velayutham, Murugesan
    Shiva, Sruti
    Sanchez, Pablo G.
    Kumar, Ajay
    D'Cunha, Jonathan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 161 (01): : E65 - E74
  • [27] Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study
    Sladden, Timothy M.
    Yerkovich, Stephanie
    Wall, Douglas
    Tan, Maxine
    Hunt, William
    Hill, Jonathan
    Smith, Ian
    Hopkins, Peter
    Chambers, Daniel C.
    JOURNAL OF TRANSPLANTATION, 2019, 2019
  • [28] Experimental ex-vivo lung perfusion with sevoflurane: Effect on damaged donor lung grafts
    Wang, X.
    Francioli, C.
    Parapanov, R.
    Marcucci, C.
    Kern, C.
    Perentes, J.
    Piguilloud, L.
    Ris, H. -B.
    Liaudet, L.
    Krueger, T.
    Gronchi, F.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 20 - 21
  • [29] PRECONDITIONING DURING EX-VIVO LUNG PERFUSION
    Valenza, Franco
    Lonati, Caterina
    Bassani, Giulia
    Leonardi, Patrizia
    Carlin, Andrea
    Rapido, Francesca
    Gatti, Stefano
    Gattinoni, Luciano
    TRANSPLANT INTERNATIONAL, 2015, 28 : 433 - 433
  • [30] Ultrastructural Changes in Epithelial and Endothelial Barriers During Ex-Vivo Lung Perfusion
    Neil, D. A.
    Andreasson, A.
    Roman, M.
    Romano, R.
    Mascaro, J.
    Tsui, S.
    Simon, A.
    Yonan, N.
    Marczin, N.
    Dark, J.
    Fisher, A. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S283 - S283